A health-related quality-of-life instrument for symptomatic patients with endometriosis: a validation study.
OBJECTIVE
This study was designed to evaluate the reliability, validity, and responsiveness of a newly developed, health-related quality-of-life measure.


METHODS
A total of 137 women (122 from a Phase III clinical trial and 15 from a private practice setting) with endometriosis completed the questionnaire several times.


RESULTS
Reproducibility and internal-consistency reliability were acceptable with intraclass correlation coefficients ranging from 0.94 to 1.00 and Cronbach's alpha coefficients ranging from 0.84 to 0.97. Construct validity was demonstrated on the basis of correlations between items and scales. Health-related quality of life varied in a consistent manner according to clinician-rated measures of pelvic pain and dysmenorrhea and patient-reported levels of endometriosis pain, but no relationship emerged according to the revised American Fertility Society classification. In general, the questionnaire was moderately to highly responsive to change.


CONCLUSIONS
This is the first comprehensive health-related quality-of-life questionnaire available for use with endometriosis patients that has demonstrated reliability, validity, and responsiveness.
Lewin-TAG, Inc, San Francisco, California 94107, USA.
H H
HH
Colwell
S D
SD
Mathias
D J
DJ
Pasta
J M
JM
Henning
J F
JF
Steege
D000293:Adolescent; D000328:Adult; D003710:Demography; D004715:Endometriosis / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use*; D010147:Pain Measurement / Q000379:methods; D011594:Psychometrics; D011788:Quality of Life; D015203:Reproducibility of Results; D011795:Surveys and Questionnaires
D016729:Leuprolide